ScipherTM.png
Trellis Rx Furthers Commitment to Advancing the Specialty Pharmacy Practice and Patient Outcomes with Integration of Scipher Medicine® PrismRA® Precision-Medicine Technology into Clinical Pathways
October 12, 2021 08:00 ET | Scipher Medicine Corporation
ATLANTA and WALTHAM, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Trellis Rx, a leading technology-enabled specialty pharmacy services provider, today announced the integration of PrismRA®, a diagnostic...
ScipherTM.png
UPDATE - Scipher Medicine Welcomes Sam Davis as General Counsel
September 24, 2021 12:00 ET | Scipher Medicine Corporation
WALTHAM, Mass., Sept. 24, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with their most effective therapies, today announced the appointment of Sam A....
ScipherTM.png
Scipher Medicine Welcomes Sam Davis as General Counsel
September 24, 2021 09:00 ET | Scipher Medicine Corporation
WALTHAM, Mass., Sept. 24, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with their most effective therapies, today announced the appointment of Sam A....
ScipherTM.png
Scipher Medicine Welcomes John Strumbos as Chief Financial Officer
September 22, 2021 10:50 ET | Scipher Medicine Corporation
WALTHAM, Mass., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with their most effective therapies, today announced the appointment of John...
ScipherTM.png
Scipher Medicine Welcomes Chip Parkinson as Chief Commercial Officer of its Diagnostics Business
September 20, 2021 11:11 ET | Scipher Medicine Corporation
WALTHAM, Mass., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with the most effective therapy, today announces the addition of Chip Parkinson...
Exagen logo_440x386 (1).jpg
Exagen Inc. to Participate in the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference
September 13, 2021 16:15 ET | Exagen Inc.
SAN DIEGO, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the Cantor Fitzgerald Virtual Global...
15-SORRENTO-Therapeutics-Logo-FINAL.png
Sorrento Publishes Positive Initial Results of SOFUSA® Lymphatic Drug Delivery System in a Phase 1b Rheumatoid Arthritis Study Using Enbrel
August 23, 2021 15:52 ET | Sorrento Therapeutics, Inc.
Rheumatoid Arthritis (RA) is one of many chronic autoimmune conditions affecting over 20 million people in the United States (NIH, 2017).Sofusa is a revolutionary technology which delivers biologic...
22157.jpg
Global Alopecia Market Size, Share & Trends Analysis Report 2021-2028: Alopecia Areata, Cicatricial, Traction, androgenetic Alopecia
August 11, 2021 04:13 ET | Research and Markets
Dublin, Aug. 11, 2021 (GLOBE NEWSWIRE) -- The "Alopecia Market Size, Share & Trends Analysis Report by Disease Type (Alopecia Areata, Cicatricial, Traction, androgenetic Alopecia), by Treatment,...
Exagen_Full_RGB_Yahoo_600x216.png
Exagen Inc. Reports Second Quarter 2021 Results
August 09, 2021 16:05 ET | Exagen Inc.
SAN DIEGO, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended June 30, 2021. ...
FBI LOGO TM.png
Rheumatoid Arthritis Testing Market Report 2021-2028 | Size, Share, Growth, Trends, Analysis, Competitive Landscape, Revenue, Forecast
August 02, 2021 08:09 ET | Fortune Business Insights
Pune, India, Aug. 02, 2021 (GLOBE NEWSWIRE) -- The global rheumatoid arthritis testing market will derive growth from the high prevalence of the disease across the world. According to a report by...